1. World Health Organization (2017) Guidance on the use of international nonproprietary names (INNs) for pharmaceutical substances.
https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=2ahUKEwjXxPP1ofrdAhUDZVAKHdQKDaQQFjAAegQICRAC&url=http%3A%2F%2Fwww.who.int%2Fmedicines%2Fservices%2Finn%2FFINAL_WHO_PHARM_S_NOM_1570_web.pdf&usg=AOvVaw3fFsY4eRnn6HwUj1upTolN
. Accessed 21 Jun 2018
2. Aronson JK (2004) Medication errors resulting from the confusion of drug names. Expert Opin Drug Saf 3:167–172.
https://doi.org/10.1517/14740338.3.3.167
3. No author (2006) Think INN, prescribe INN, dispense INN. ISDB Newsletter 20:5–10
4. Godman B, Bishop I, Finlayson AE, Campbell S, Kwon HY, Bennie M (2013) Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries. Expert Rev Pharmacoecon Outcomes Res 13:469–482.
https://doi.org/10.1586/14737167.2013.820956
5. OECD (2010) Value for money in health spending (table 6.1). OECD health policy studies.
https://read.oecd-ilibrary.org/social-issues-migration-health/value-for-money-in-health-spending_9789264088818-en#page176
. Accessed 21 Jun 2018